DB16677InvestigationalProtein Based Therapies
Nadecnemab is under investigation in clinical trial NCT03956550 (A Study to Examine the Efficacy and Safety of REGN5069 in Patients With Pain Due to Osteoarthritis of the Knee).
- Code names
- REGN-5069
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Nadecnemab, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account